We propose an approach that allows simultaneous determination of the levels of M and G isotypes of antibodies to the panel of glycans using microarrays. The level of IgG antibodies to 3’-O-su-Lea glycan detects patients with colorectal cancer with a sensitivity of 69.77% and specificity of 62.75%. The percentage of correctly classified colorectal cancer patients with the use of a combination of two markers IgM antibodies to glycans 3’-sialyl-TF and 3’-O-su-Lea is as high as 74.23%. The levels of IgM antibodies to 3’-O-su-Lea glycan differ significantly in patients with and without regional metastases. The levels of some of antiglycan IgM or IgG antibodies differed significantly in patients with tumors of different location and differentiation.
Similar content being viewed by others
References
Borrebaeck CA. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat. Rev. Cancer. 2017;17(3):199-204.
Butvilovskaya VI, Popletaeva SB, Chechetkin VR, Zubtsova ZI, Tsybulskaya MV, Samokhina LO, Vinnitskii LI, Ragimov AA, Pozharitskaya EI, Grigor Eva GA, Meshalkina NY, Golysheva SV, Shilova NV, Bovin NV, Zasedatelev AS, Rubina AY. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med. 2016;5(7):1361-1372.
Cao X, Wen ZS, Sun YJ, Li Y, Zhang L, Han YJ. Prognostic value of ABO blood group in patients with surgically resected colon cancer. Br. J. Cancer. 2014;111(1):174-180.
Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, Sturgeon C. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int. J. Cancer. 2014;134(11):2513-2522.
Geissner A, Seeberger PH. Glycan arrays: from basic biochemical research to bioanalytical and biomedical applications. Annu. Rev. Anal. Chem. (Palo Alto Calif). 2016;9(1):223-247.
Jacob F, Anugraham M, Pochechueva T, Tse BW, Alam S, Guertler R, Bovin NV, Fedier A, Hacker NF, Huflejt ME, Packer N, Heinzelmann-Schwarz VA. The glycosphingolipid P 1 is an ovarian cancer-associated carbohydrate antigen involved in migration. Br. J. Cancer. 2014;111(8):1634-1645.
Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin. Proteomics. 2011;8(1):7. doi: https://doi.org/10.1186/1559-0275-8-7.
Muthana SM, Gildersleeve JC. Glycan microarrays: powerful tools for biomarker discovery. Cancer Biomark. 2014;14(1):29-41.
Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer. 2015;15(9):540-555.
Pochechueva T, Chinarev A, Schoetzau A, Fedier A, Bovin NV, Hacker NF, Jacob F, Heinzelmann-Schwarz V. Blood plasma-derived anti-glycan antibodies to sialylated and sulfated glycans identify ovarian cancer patients. PLoS One. 2016;11(10):e0164230. doi: https://doi.org/10.1371/journal.pone.0164230.
Rubina AY, Dementieva EI, Stomakhin AA, Darii EL, Pan’kov SV, Barsky VE, Ivanov SM, Konovalova EV, Mirzabekov AD. Hydrogel-based protein microchips: manufacturing, properties, and applications. Biotechniques. 2003;34(5):1008-1022.
Tikhonov AA, Tsybulskaya MV, Butvilovskaya VI, Savvateeva EN, Belousov PV, Kuprash DV, Solopova ON, Chernichenko MA, Filushin MM, Rubina AY. Differential quantification of SCCA1 and SCCA2 cancer antigens using a hydrogel biochip. Anal. Methods. 2016;8(44):7920-7928.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015;65(2):87-108.
Vollmers HP, Brändlein S. Natural antibodies and cancer. N. Biotechnol. 2009;25(5):294-298.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 10, pp. 485-490, October, 2018
Rights and permissions
About this article
Cite this article
Tikhonov, A.A., Savvateeva, E.N., Chernichenko, M.A. et al. Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer. Bull Exp Biol Med 166, 489–493 (2019). https://doi.org/10.1007/s10517-019-04379-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04379-2